Annika Rössler, PhD
Annika Rössler, PhD
Postdoctoral Research Fellow | Harvard Medical School | CVVR | Beth Israel Deaconess Medical Center
Verified email at - Homepage
Cited by
Cited by
SARS-CoV-2 Omicron variant neutralization in serum from vaccinated and convalescent persons
A Rössler, L Riepler, D Bante, D von Laer, J Kimpel
New England Journal of Medicine 386 (7), 698-700, 2022
Postacute COVID-19 is characterized by gut viral antigen persistence in inflammatory bowel diseases
A Zollner, R Koch, A Jukic, A Pfister, M Meyer, A Rössler, J Kimpel, ...
Gastroenterology 163 (2), 495-506. e8, 2022
Successful return to professional men’s football (soccer) competition after the COVID-19 shutdown: a cohort study in the German Bundesliga
T Meyer, D Mack, K Donde, O Harzer, W Krutsch, A Rössler, J Kimpel, ...
British journal of sports medicine 55 (1), 62-66, 2021
Comparison of four SARS-CoV-2 neutralization assays
L Riepler, A Rössler, A Falch, A Volland, W Borena, D von Laer, J Kimpel
Vaccines 9 (1), 13, 2020
SARS-CoV-2 B. 1.1. 529 variant (Omicron) evades neutralization by sera from vaccinated and convalescent individuals
A Rössler, L Riepler, D Bante, D von Laer, J Kimpel
MedRxiv, 2021
Neutralization profile after recovery from SARS-CoV-2 omicron infection
A Rössler, L Knabl, D von Laer, J Kimpel
New England Journal of Medicine 386 (18), 1764-1766, 2022
B and T cell response to SARS-CoV-2 vaccination in health care professionals with and without previous COVID-19
A Zollner, C Watschinger, A Rössler, MR Farcet, A Penner, V Böhm, ...
EBioMedicine 70, 2021
High SARS-CoV-2 seroprevalence in children and adults in the Austrian ski resort of Ischgl
L Knabl, T Mitra, J Kimpel, A Rössler, A Volland, A Walser, H Ulmer, ...
Communications medicine 1 (1), 4, 2021
BA. 2 and BA. 5 omicron differ immunologically from both BA. 1 omicron and pre-omicron variants
A Rössler, A Netzl, L Knabl, H Schäfer, SH Wilks, D Bante, ...
Nature communications 13 (1), 7701, 2022
Oncolytic virotherapy enhances the efficacy of a cancer vaccine by modulating the tumor microenvironment
I Koske, A Rössler, L Pipperger, M Petersson, I Barnstorf, J Kimpel, ...
International journal of cancer 145 (7), 1958-1969, 2019
Heterologous ChAdOx1/BNT162b2 vaccination induces stronger immune response than homologous ChAdOx1 vaccination: The pragmatic, multi-center, three-arm, partially randomized …
Z Banki, J Mateus, A Rössler, H Schäfer, D Bante, L Riepler, A Grifoni, ...
EBioMedicine 80, 2022
Marked increase in avidity of SARS-CoV-2 antibodies 7–8 months after infection is not diminished in old age
D Pichler, M Baumgartner, J Kimpel, A Rössler, L Riepler, K Bates, ...
The Journal of Infectious Diseases 224 (5), 764-770, 2021
Prevalence of SARS-CoV-2 IgG antibodies in a large prospective cohort study of elite football players in Germany (May–June 2020): implications for a testing protocol in …
D Mack, BC Gärtner, A Rössler, J Kimpel, K Donde, O Harzer, W Krutsch, ...
Clinical Microbiology and Infection 27 (3), 473. e1-473. e4, 2021
N-chlorotaurine is highly active against respiratory viruses including SARS-CoV-2 (COVID-19) in vitro
M Lackner, A Rössler, A Volland, MN Stadtmüller, B Müllauer, Z Banki, ...
Emerging Microbes & Infections 11 (1), 1293-1307, 2022
Reduced sensitivity of antibody tests after omicron infection
A Rössler, L Knabl, LM Raschbichler, E Peer, D von Laer, W Borena, ...
The Lancet Microbe 4 (1), e10-e11, 2023
Characterizing SARS-CoV-2 neutralization profiles after bivalent boosting using antigenic cartography
A Rössler, A Netzl, L Knabl, D Bante, SH Wilks, W Borena, D Von Laer, ...
Nature Communications 14 (1), 5224, 2023
Persistence of immunity to SARS-CoV-2 over time in the ski resort Ischgl
W Borena, Z Bánki, K Bates, H Winner, L Riepler, A Rössler, L Pipperger, ...
EBioMedicine 70, 2021
The anti-histamine azelastine, identified by computational drug repurposing, inhibits infection by major variants of SARS-CoV-2 in cell cultures and reconstituted human nasal …
R Konrat, H Papp, J Kimpel, A Rössler, V Szijártó, G Nagy, M Madai, ...
Frontiers in Pharmacology 13, 861295, 2022
Immune response after two doses of the BNT162b2 COVID-19 vaccine and risk of SARS-CoV-2 breakthrough infection in Tyrol, Austria: an open-label, observational phase 4 trial
L Seekircher, Z Bánki, J Kimpel, A Rössler, H Schäfer, B Falkensammer, ...
The Lancet Microbe 4 (8), e612-e621, 2023
Neutralization profile of Omicron variant convalescent individuals
A Rössler, L Knabl, D Laer, J Kimpel
medRxiv, 2022.02. 01.22270263, 2022
The system can't perform the operation now. Try again later.
Articles 1–20